Navigation Links
QB3, Deloitte collaborate to drive California bioscience innovation

The California Institute for Quantitative Biosciences (QB3) has entered into a collaboration with Deloitte to help the institute in its efforts to convert bioscience innovation into a driver for jobs, companies and improved health in California.

Deloitte, which provides consulting, audit, tax and financial advisory services, will provide its services at no cost to help QB3 develop an "innovation ecosystem," bringing together the four pillars of the bioscience community academic research, government, industry and investors to work in unison toward a common vision of economic growth and better health.

"The California economy and life sciences industry seem to be caught in an almost desperate search for creative new approaches," said QB3 Director Regis Kelly, PhD. "We see the 'innovation ecosystem' project as the start of an ongoing effort with Deloitte to generate the kind of creative solutions that are needed now and into the future."

The collaboration includes a commitment from Deloitte's life science practice, which started working with QB3 in December 2010 to assess how California compares to other states in fostering bioscience innovation. Deloitte will continue to contribute its organizational experience in the life sciences to offer perspectives on operations and business models from other states, as well as insights on collaborations and federal policy. This, in turn, will help QB3 in its efforts to generate new approaches to working within the rapidly changing biotech industry.

"Our collaboration with QB3 is one of the largest life science initiatives and investments for Deloitte's life sciences practice," said Christie Smith, PhD, principal, Deloitte Consulting LLP and Northern Pacific sector leader for life sciences. "This opportunity allows Deloitte to bring its capabilities in audit, tax, financial advisory services and consulting to aid QB3 in achieving its mission."

The services will include strategic analysis and planning, as well as project management, to extend QB3's relationships with government, universities, investors and bioscience companies in an effort to both motivate investments in innovation and help move ideas from lab to market more quickly. It also will include third-party feedback on QB3's impact and success over the last decade in creating jobs, supporting entrepreneurs and growing California's bioeconomy.

The team's deliberate focus on the four stakeholder communities is what makes this initiative so unusual, Kelly said, but also could be the root of its success in helping to "unclog the pipeline" that leads from scientific discoveries to real-world benefits for patients.

It represents a challenge, as well, in fostering a united mission among large and small companies, sophisticated investors, top-ranked researchers and entrepreneurs, according to Matthew K. Hudes, Deloitte's U.S. leader for biotechnology.

"The problems in life sciences cannot be solved without the key players working together, not only from the private and public sector, but also from university researchers who are the starting point for innovative breakthroughs," Hudes said. "Our goal is to develop a model for an innovation ecosystem that enables those breakthroughs to improve human health worldwide."

In a separate initiative, Deloitte and QB3 will launch a program of bioscience industry awards and speaker forums to recognize scientific innovators and entrepreneurs, and provide a platform for networking and learning.


Contact: Kristen Bole
University of California - San Francisco

Related medicine news :

1. Hope Phones, IntraHealth and FrontlineSMS:Medic Collaborate on Phone Donation Campaign to Support Health Workers in Africa
2. The Advisory Board Company and HIMSS Analytics to Collaborate to Solve Health Care IT Challenges
3. Philips Collaborates with Microsoft to Enhance Healthcare Efficiencies and Productivity
4. FDA, FSIS, CDC Collaborate on Methods to Measure Success of Food Safety Programs
5. Eisner USA, LLC Collaborates with Surgical Review Corp to Provide Innovative Bariatric Devices to Bariatric Surgery Center of Excellence (BSCOE) Participants
6. Doctors must collaborate so that patients get full benefit of tamoxifen treatment
7. PeopleStreme Collaborates with SkillSoft for Learning Management Content
8. BCS Global and Iformata Sign Agreement to Collaborate on the PSVN Initiative to Deliver B2B Video Communications
9. Two Hand Therapy Organizations Collaborate on Jam-Packed Educational Weekend
10. Carefx to Collaborate with the Cleveland Clinic to Commercialize CCF Business Intelligence Solution
11. Elsevier and InfoDesk collaborate to co-develop federated drug pipeline intelligence solution
Post Your Comments:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the addition ... - Forecast to 2022" report to their offering. ... to date financial data derived from varied research sources to ... potential impact on the market during the next five years, ... of sub markets, regional and country level analysis. The report ...
(Date:6/23/2016)... , June 23, 2016 Bracket , ... launch its next generation clinical outcomes platform, Bracket eCOA (SM) ... held on June 26 – 30, 2016 in ... first electronic Clinical Outcome Assessment product of its kind to ... #715. Bracket eCOA 6.0 is a flexible platform ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas ... Brasil as the company,s second affiliate in Latin America . ... ... of Astellas Farma Colombia ... ...
Breaking Medicine Technology: